Literature DB >> 19822256

IDO and outcomes in ovarian cancer.

Brad H Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19822256     DOI： 10.1016/j.ygyno.2009.09.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

1.  Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer.

Authors:  Soumyabrata Roy; Shyamal Goswami; Anamika Bose; Krishnendu Chakraborty; Smarajit Pal; Atanu Haldar; Parthasarathi Basu; Jaydip Biswas; Rathindranath Baral
Journal:  Clin Vaccine Immunol       Date:  2011-02-09

2.  Strong Correlation of Indoleamine 2,3-Dioxygenase 1 Expression with Basal-Like Phenotype and Increased Lymphocytic Infiltration in Triple-Negative Breast Cancer.

Authors:  Sewha Kim; Sanghui Park; Min Sun Cho; Woosung Lim; Byung-In Moon; Sun Hee Sung
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

Review 3.  Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase.

Authors:  Kashif Asghar; Asim Farooq; Bilal Zulfiqar; Asif Loya
Journal:  World J Clin Oncol       Date:  2021-06-24

4.  Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.

Authors:  Grégoire Wieërs; Nathalie Demotte; Danièle Godelaine; Pierre Van der Bruggen
Journal:  Cancers (Basel)       Date:  2011-07-18       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.